Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
Covington
Boehringer Ingelheim
Citi
Novartis
Moodys
Dow
Merck
Mallinckrodt
Fish and Richardson

Generated: October 22, 2017

DrugPatentWatch Database Preview

Details for Patent: 6,166,043

« Back to Dashboard

Summary for Patent: 6,166,043

Title: Pharmaceutical composition
Abstract:Pharmaceutical composition which comprises an insulin sensitivity enhancer in combination with other antidiabetics differing from the enhancer in the mechanism of action, which shows a potent depressive effect on diabetic hyperglycemia and is useful for prophylaxis and treatment of diabetes.
Inventor(s): Ikeda; Hitoshi (Higashiosaka, JP), Sohda; Takashi (Takatsuki, JP), Odaka; Hiroyuki (Kobe, JP)
Assignee: Takeda Chemical Industries, Ltd. (Osaka, JP)
Application Number:09/303,492
Patent Claim Types:
see list of patent claims
Use;

No matches for this query

International Patent Family for Patent: 6,166,043

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina005641► Subscribe
Argentina061195► Subscribe
Argentina065389► Subscribe
Argentina091289► Subscribe
Austria256463► Subscribe
Austria438397► Subscribe
Australia5603496► Subscribe
Australia723097► Subscribe
Canada2179584► Subscribe
Canada2531834► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

McKesson
US Army
QuintilesIMS
Covington
Moodys
Cantor Fitzgerald
Fish and Richardson
Deloitte
Accenture
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot